Register for the Fierce Coronavirus Virtual Series
Join us the week of March 30th for a series of virtual updates and expert panels discussing the coronavirus
Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.
GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.
Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.